Literature DB >> 18352767

Management of complicated shunt infections: a clinical report.

Hector E James1, John S Bradley.   

Abstract

OBJECTIVES: The authors present their experience with a protocol for the treatment of patients with complicated shunt infections.
METHODS: Complicated shunt infections are defined for the purpose of this protocol as multiple compartment hydrocephalus, multiple organism shunt infection, severe peritonitis, or infections in other sites of the body. The initial treatment protocol for these patients was 3 weeks of intravenous antibiotic therapy and 2 weeks of twice daily intraventricular/intrashunt antibiotic therapy. Cerebrospinal fluid (CSF) cultures were monitored during therapy and obtained again 48 hours after completion. The shunt was completely replaced. Additionally, follow-up cultures were obtained in all patients 3-6 months after therapy was completed.
RESULTS: A cure of the infection was achieved in all patients as defined by negative cultures obtained at completion of antibiotic therapy and in follow-up studies. The follow-up period was 2-11 years (mean 4.4 +/- 2.5 years). The treatment protocol was modified in the patients treated after 1991, and 18 patients were treated with this modified treatment regime. In these patients, intraventricular antibiotics were administered only once daily for 14 days, and the CSF was cultured 24 hours after antibiotic therapy had been stopped instead of after 48 hours. The results were similar to those obtained with the initial protocol.
CONCLUSIONS: Based on their prospective nonrandomized series, the authors believe that patients with complicated shunt infections can be successfully treated with 2 weeks of intraventricular antibiotic therapy administered once daily, concurrent with 3 weeks of intravenous antibiotic therapy. This protocol reduces length of treatment and hospital stay, and avoids recurrence of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18352767     DOI: 10.3171/PED/2008/1/3/223

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  4 in total

1.  Microbiology and treatment of cerebrospinal fluid shunt infections in children.

Authors:  Daniel J Adams; Michael Rajnik
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

2.  Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.

Authors:  Roger Bayston; Gautham Ullas; Waheed Ashraf
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

3.  Treatment strategies for cerebrospinal shunt infections: a systematic review of observational studies.

Authors:  Joan L Robinson; Dolores Freire; Liza Bialy
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

Review 4.  Evaluation of the ventriculocholecystic shunt-an overview of present practice in adult and pediatric hydrocephalus.

Authors:  Cezar Octavian Morosanu; Adelina Priscu; Ioan Stefan Florian
Journal:  Neurosurg Rev       Date:  2021-01-22       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.